The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world evaluation of clinical outcomes and long-term survivors in patients with BRAF-V600E metastatic colorectal cancer.
 
William Phillips
No Relationships to Disclose
 
Mohammad Alrehaili
No Relationships to Disclose
 
Horia Marginean
No Relationships to Disclose
 
Tim Asmis
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; MEDIAN Technologies; Merck; Pfizer; Taiho Oncology
 
Michael M. Vickers
No Relationships to Disclose
 
Bryan Lo
Consulting or Advisory Role - AstraZeneca; Bayer; Novartis; Pfizer; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); EMD Serono (Inst); Roche (Inst)
 
Rachel Anne Goodwin
Honoraria - Advanced Accelerator Applications; Eisai; Incyte; Incyte; Ipsen; Merck; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Amgen; Apobiologix; Astellas Pharma; AstraZeneca Canada; Bayer; Eisai; Incyte; Ipsen; Merck; MSD; Novartis; Pfizer; Roche Canada; Taiho Pharmaceutical; Viatris
Speakers' Bureau - Amgen; Bayer; Bayer; Eisai; Ipsen; Merck; Mylan; Pfizer
Research Funding - Eisai; Ipsen
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer